The study's purposes are to identify patient characteristics, treatment response and survival rate, and to describe the important prognostic factors for our patients with extranodal head and neck lymphoma. Furthermore, no study has systemically discussed the overall figure of this disease in Taiwan and we analyzed our data on this topic. A retrospective review was performed for 86 patients with extranodal head and neck lymphoma, diagnosed in Kaohsiung Medical University Hospital, between 1990 and 2007. We evaluated the medical records and analyzed the possible factors affecting treatment outcomes, survival rate, and free-from-disease (FFD) survival rate. Forty-nine male and 37 female patients were included with a male:female ratio of 1.32：1. The most frequent histologic type was diffuse large B cell lymphoma, accounting for 41.9% of the total. The most common primary site involved with extranodal head and neck non-Hodgkin's lymphoma was a tonsil with 27 cases (31.4%). Stage, international prognostic index (IPI) score, B symptoms, lactate dehydrogenase (LDH) level, and lymph node status significantly affected treatment response. The overall 5-and 10-year survival rates were 68.0% and 57.8%, respectively. The FFD survival rate was 53.6% and 49.3% at 5 and 10 years, respectively. Factors including stage, lymph node status, LDH level, and IPI score produced significant differences in both overall survival and FFD survival. Our analyzed information is similar to other previously presented studies. Stage, IPI score, B symptoms, LDH level, and neck nodal status can be used to evaluate the treatment outcomes. Neck nodal status and stage are the two significant prognostic factors for overall survival.
Introduction
Lymphoma can be classified as Hodgkin disease and non-Hodgkin disease. Extranodal Hodgkin disease is rarely present; however, about 25% of patients with non-Hodgkin lymphoma (NHL) manifest extranodally [1] , of whom 33% have the primary site at the head and neck area [2] . Statistically, extranodal head and neck NHL represents 4e15% of NHL patients.
Extranodal head and neck NHL comprises a group of various tumors with different histology, treatment response and prognosis. Many series have reviewed the characteristics of the disease worldwide; however, no article has systemically discussed the overall figure of this topic in Taiwan. Our retrospective study aims to identify patient characteristics, treatment response and survival rate, as well as to describe the important prognostic factors for these patients.
Materials and methods
We used the lymphoma database in Kaoshiung Medical University Hospital, Taiwan, to identify extranodal lymphoma of the head and neck area from 1990 to 2007 (86 cases in total). The charts of these patients were reviewed to record gender, age at diagnosis, histologic type, grading, primary site, treatment protocol and response, and survival time. We also recorded the possible prognostic factors. The World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues (fourth edition) was used to classify and grade the tumors, along with the Ann Arbor staging system. Overall survival and free-from-disease (FFD) survival were calculated from time of diagnosis until death and recurrence respectively, or until last follow-up. Treatment response was classified into complete response (100% resolution), partial response (50e100% resolution), no response (<50% resolution), and progression of disease (tumor enlarging after treatment). The international prognostic index (IPI) is a clinical tool developed by oncologists to aid in predicting the prognosis of patients with aggressive NHL and we used this in our study. Statistics with KaplaneMeier survival plots and the Cox regression test was performed to evaluate survival rate and identify possible significant factors in survival. The binomial test was used to evaluate the predisposing factors affecting treatment response.
Results
Of the 101 patients reviewed, 86 were included in the study. Cases with incomplete data and lack of follow-up were excluded. Patient and disease characteristics are described in Table 1 . The age at presentation ranged from 6 to 89 years with a mean of 55 years and a peak in the seventh decade. Forty-nine patients were male and 37 female, giving a male:female ratio of 1.32：1. The distribution did not reveal a significant difference in gender. Of the 86 patients, 13 cases (16.5%) had B symptoms (body weight loss, fever and night sweating). Early stage (stages I and II) accounts for 69 cases (80.2%) and late stage (stages III and IV) for 17 cases (19.8%). Excluding the 13 unavailable patients, the grading of tumors was classified into low, intermediate and high, with numbers of 12, 59 and 2, respectively. Metastasis of regional neck lymph nodes was noted in 39 (45.3%) tumors. There were 17 individuals with high-level lactate dehydrogenase (LDH), and 51 (75.0%) within the normal range, according to the available data. Patients with low IPI scores (0e1) represented 70.4% of the total (n Z 50). Table 1 also shows treatment modality including chemotherapy, surgery, radiotherapy, and combination therapy with at least two kinds of therapies. Combination treatment modality was performed in 33 tumors (41.8%) and chemotherapy alone in 46 (58.2%). The doses of radiotherapy ranged from 2400 cGy to 6840 cGy, with a median of 4000 cGy. Common regimens of chemotherapy were mainly based on cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) with some variations. Sixtyfour patients were noted with complete response and 22 without. The complete response rates between various subgroups, and tumor characteristics were evaluated by the binomial test. Several factors which significantly affected complete response are also described in this table.
As shown in Table 2 , the most common primary site involved by extranodal head and neck NHL was a tonsil, with 27 cases (31.4%). Cases of the Waldeyer's ring, including tonsil, nasopharynx and tongue base, reached as high as 50% (43 patients). The area of the sinus and nasal cavity was the second most common site affected, with 14 cases (16.3%). The distribution of other sites is also shown.
The most frequent histologic type was diffuse large B cell lymphoma, consisting of 41.9% of the total (n Z 36). The second most common type was small lymphocytic lymphoma (n Z 7; 8.1%) and all other types accounted for 43 cases (50%).
Live patients were followed for a median duration of 63.0 months (range: 2e187 months). Twenty-nine deaths were recorded. The overall 5-and 10-year survival rates were 68.0% and 57.8%, respectively (Fig. 1A) . The FFD survival rate was 53.6% and 49.3% at 5 and 10 years, respectively ( Fig. 1B) . Among the 11 possible risk factors affecting overall survival and FFD survival ( 
Discussion
Many series have studied the various properties of extranodal NHL of the head and neck worldwide. However, no article has discussed the overall figure of this topic in Taiwan. In our study, the clinicopathologic characteristics, therapeutic protocol, treatment response and prognosis were retrospectively reviewed and we tried to identify the profile of the disease in Taiwan.
The median age of the cases was 55 years. Several series (55e57.5 years) have shown results which are consistent with our data. We found the peak incidence to be in the seventh decade, which is the same as found in other studies [3, 4] . Economoponlos et al. [5] and Shine et al. [6] reported the peak to be in the sixth decade. There was no significant difference in sex distribution, as was the case in other studies [1, 3, 7, 8] . However, two other studies found a significant male predominance in incidence: Sasai et al. [9] reported 68 males and 42 females; and Shima et al. [4] presented 69 males and 45 females.
On viewing the primary site of the head and neck extranodal lymphoma, tonsils were the most commonly involved areas in our series (31.4% of the total), which is consistent with other investigators [1e3,10]. Cases occurring in paranasal sinus and nasal cavity accounted for 16.3% of our patients, and these regions were the second most common primary site in the study. Several series described the range to be from 12.5% to 16.7% [1, 11, 12] . As expected, diffuse large B cell lymphoma was the most frequent histologic type (41.9%; n Z 36) [3, 9] . Only 16.5% of patients had B symptoms in our study, while some authors reported figures from 10% to 15% [3, 13] . In general, the incidence of B symptoms in the patients with NHL is similar to our data.
There is no doubt that most extranodal NHLs of head and neck are found in the early stage. For Hanna et al. [14] , 75% and 25% of patients were in the early (stages I þ II) and advanced (stages IIIþ IV) stages, respectively, while Jacobs et al. [12] found 66% of cases in the early stage, both of which are similar to our results (80.2%).
Analysis of factors influencing treatment response and survival rate require the adjustment of IPI in NHL (zero and one factor vs. more than one factor) to identify possible groups with a better treatment response and higher survival rate. In one published study, the authors implied that the modification of IPI may better reflect prognostic value among low-risk patients [13] .
The treatment modality of head and neck extranodal NHL was influenced by many factors, which included the clinical stage, institutional protocol, or health conditions of patients. Thirty-six percent (n Z 28) of our patients received radiotherapy and most also received additional therapies (chemotherapy or surgery). Chemotherapy based on CHOP may be aggressive for disease control and if needed, additional therapy (including radiotherapy or surgery) is considered to be the better treatment plan [12] . Some studies noted that the effect of radiotherapy with chemotherapy was better than chemotherapy alone [13, 15] . In one review, although combination treatment had no significant overall survival advantage, it was significantly associated with better disease-free survival [13] . Aviles et al. [15] concluded that, in cases of localized NHL of head and neck, radiotherapy with chemotherapy produced significantly better overall survival than chemotherapy alone. However, because of the small number of our patients, we could not achieve the same results.
Some series have noted several adverse factors for treatment response, such as old age, bulky lymph node, higher IPI score, and advanced stage [13, 16, 17] . In our study, using univariate analysis, we compared the subgroups of 11 factors and found that advanced stage, higher IPI scores, B symptoms, high levels of LDH, and the presence of neck nodal adenopathy, with significance, adversely affected treatment response with a lower complete response rate. As a result, we can predict the tumor response after therapeutic plan, using these factors.
The overall 5-and 10-year survival rates (68.0% and 57.8%, respectively) in our study were not significantly different from these of other series. Economopoulos et al. [5] reported 65% at 5-year overall survival rate. MacDermed et al. [17] also demonstrated rates of 92% and 70% of 5-and 10-year overall survival, respectively. The FFD survival rates of our patients at 5 and 10 years were 53.6% and 49.3%, respectively. Several investigators had similar results [1, 5, 14, 18] .
There were some causes for the variation between the studies, including the various complex classification system of lymphomas, inter-institutional differences in therapeutic regimens (selection criteria of protocol, dosage or treatment cycles), racial differences, and patient selection (smaller sample size) [3] . After comparing the subgroups of the 11 factors by the use of univariate analysis, the data revealed that advanced stage (p Z 0.007), higher IPI score (p Z 0.01), high LDH level (p Z 0.027), and neck nodal diseases (p Z 0.033) adversely affected overall survival and FFD survival, with significance. Furthermore, multivariate analysis showed that neck nodal status and stage were the two significant prognostic factors for overall survival in our study. We have reviewed several studies and only two articles evaluated the influence of neck lymphadenopathy on survival [13, 19] :. Both articles concluded that regional nodes did not predict overall survival. However, abnormal neck lymph nodes were shown to have poor influence on prognosis in our study. We consider that the different results may be because of population selection. Subjects in the two studies were specific subgroups of extranodal head and neck lymphoma, but our patients were from the general population of the disease. Therefore, neck nodal status can be viewed as an independent index for prognosis. Patients in the advanced stage had a worse survival rate. The effect of stage has been emphasized repeatedly in many studies and our data are in agreement [2, 4, 5, 20] .
In conclusion, we reviewed the general characteristics of extranodal NHL of the head and neck and, to the best of our knowledge, this is the first systemic analysis in Taiwan. The information included here is similar to other previous studies. Several factors, includung stage, IPI score, B symptoms, LDH level, and neck nodal status, can be used to evaluate the treatment response. Overall survival and FFD survival can be evaluated with the prognostic effects of tumor stage, IPI score, LDH level, and neck nodal status. In particular, neck nodal status and stage are the two significant prognostic factors for overall survival.
